September 12, 2006 – PHILADELPHIA — Consumption of Vitamin D tablets was found to cut the risk of pancreatic cancer nearly in half, according to a study led by researchers at […]
Threshold Pharmaceuticals Completes Enrollment in Phase 3 and Phase 2 Trials for the Treatment of Pancreatic Cancer
Press Release
Amplimed Pancreatic Cancer Protocol for Phase I Trial
Amplimed Pancreatic Cancer Protocol for Phase I Trial By Webmaster Posted on 12/25/2004 A phase I Trial of Imexon Injection (Amplimexon) plus Gemcitabine in Advanced, Previously Untreated Pancreatic Adenocarcinoma • […]